ClinConnect ClinConnect Logo
Search / Trial NCT07133243

Testicular Torsion Evaluation by ultraSonography Technic Imaging

Launched by CENTRE HOSPITALIER DE ROUBAIX · Aug 19, 2025

Trial Information

Current as of November 13, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way to quickly check for testicular torsion, a painful condition where the testicle twists and can lose blood flow. The study will see how well an emergency doctor’s ultrasound exam (a safe imaging test using sound waves) matches the final diagnosis made by a specialist surgeon during surgery, which is the most accurate way to confirm testicular torsion. The goal is to find out if emergency doctors can reliably use ultrasound to diagnose this condition faster, which could help get patients treated sooner.

Men between 16 and 70 years old who come to the emergency room with sudden pain in one testicle that started within the last 3 days may be eligible. Participants will have an ultrasound done by the emergency doctor when they arrive, and if surgery is needed, the surgeon’s findings will be compared to the ultrasound results. This study is currently not recruiting patients yet. If the emergency doctors’ ultrasound results match the surgeons’ findings well, it could improve how testicular torsion is diagnosed and treated in emergency settings.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Male patients
  • Minimum age of 16 years and maximum age of 70 years
  • Presenting with unilateral testicular pain lasting less than 72 hours
  • Admitted to the Roubaix Hospital Emergency
  • Presence of an emergency physician trained in performing testicular ultrasound during the transition to the Emergency unit
  • Patient who did not object to participating in the study
  • Exclusion Criteria:
  • Recent history (less than one month) of ipsilateral testicular torsion, testicular trauma, or testicular surgery
  • Patient with a history of sex reassignment, currently undergoing sex reassignment, or taking sex reassignment hormones
  • Innate or acquired absence of one of the two testicles within the scrotum
  • Patient who has already been included once in the TESTI study

About Centre Hospitalier De Roubaix

The Centre Hospitalier de Roubaix is a leading healthcare institution in France dedicated to advancing medical research and improving patient care through innovative clinical trials. With a multidisciplinary team of healthcare professionals and researchers, the center focuses on a wide range of therapeutic areas, aiming to enhance treatment options and outcomes for patients. The institution prioritizes ethical standards and rigor in its research processes, fostering collaboration with academic institutions and industry partners to drive forward the frontiers of medical knowledge. Through its commitment to excellence and patient-centered care, the Centre Hospitalier de Roubaix plays a crucial role in the development of novel therapies and contributes to the advancement of public health.

Locations

Roubaix, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported